Navigation Links
Mithridion wins grants for Alzheimer's research

Madison, Wis. - Mithridion, Inc., a biopharmaceutical startup that is developing drugs to disrupt the progress of Alzheimer's disease, has secured $296,800 in federal grants to evaluate tests for drug candidates.

The twin grants, awarded by the National Institute on Aging, a branch of th......

Full article >>> the brain that might shield neurons from Amyloid beta, the primary toxin in Alzheimers.

"The advantage of small molecules is that they can be synthesized by chemical means, they can be accurately analyzed, they are relatively low cost for production, and they have a very well-trodden path for getting Food and Drug Administration approval," Twose sa......

Full article >>> > "That's a major advantage and it really stimulates innovation," Twose said. "These grants are really the lifeblood of many, many biotech companies."

......

Full article >>>
'"/>

Source:wistechnology.com By Chris Fleissner 08/29/06


Related biology technology :

1. Mithridion raises $1.6M through angel networks
2. Digital Healthcare Conference, Mithridion, lack of degrees
3. Madison-based Mithridion seeks to capitalize on Alzheimers breakthrough
4. State to offer $850K in high-tech training grants
5. Venture-backed firms could become eligible for federal SBIR grants
6. NASDAQ grants Merge more time for compliance
7. Morgridge seed grants attract over 220 proposals
8. Medical College researchers win federal grants
9. NSF grants bolster integrative graduate study at UW-Madison
10. Three state businesses receive technology grants
11. Visonex plans to expand with state grants, loan
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... , ... December 01, 2016 , ... ... long-term client Nanowear on their recent FDA Class II 510(k) clearance for their ... significant hurdle in commercializing remote cardiac monitoring devices that rely on cloth-based nanosensors. ...
(Date:12/2/2016)... bioLytical Laboratories, a world leader in rapid infectious disease tests, introduced the Company,s newest ... members. (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) Continue Reading ... ... , , bioLytical was invited ... introduce the INSTI HIV Self Test to 350 pharmacy representatives in Nairobi ...
(Date:11/30/2016)... Nov. 30, 2016 Biotest Pharmaceuticals Corporation (BPC), ... to announce the addition of its newest plasma collection ... Nebraska . The 15,200 square foot state-of-the-art facility ... 2016 and brings the total number of BPC,s plasma ... Carlisle , BPC,s Chief Executive Officer said "We are ...
(Date:11/30/2016)... November 2016   Merck , ein ... Unterzeichnung einer Reihe von Vereinbarungen mit Evotec ... AG Screeningleistungen für Mercks Palette genetischer Reagenzien ... auf diese Bibliotheken in Kombination mit Evotecs ... Weg zur Ermittlung und Erforschung neuer Arzneimitteltargets.    ...
Breaking Biology Technology:
(Date:11/29/2016)... CANNES, France , November 29, 2016 Nearly ... Continue Reading ... ... System is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric ...
(Date:11/21/2016)... Nov. 21, 2016   Neurotechnology , a ... technologies, today announced that the MegaMatcher On Card ... submitted for the NIST Minutiae Interoperability Exchange ... the mandatory steps of the evaluation protocol. ... continuing test of fingerprint templates used to establish ...
(Date:11/15/2016)... 2016  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... the gut microbiome, today announced the pricing of ... its common stock and warrants to purchase 50,000,000 ... to the public of $1.00 per share and ... the offering, excluding the proceeds, if any from ...
Breaking Biology News(10 mins):